Literature DB >> 12118036

More concern about transfusion requirement when evaluating quality of life in anemic patients.

Esther N Oliva, Arianna D'Angelo, Bruno Martino, Francesco Nobile, Borislav D Dimitrov, Annalisa Perna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12118036     DOI： 10.1200/JCO.2002.20.14.3182

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  Quality of life in elderly patients with acute myeloid leukemia: patients may be more accurate than physicians.

Authors:  Esther N Oliva; Francesco Nobile; Giuliana Alimena; Francesca Ronco; Giorgina Specchia; Stefana Impera; Massimo Breccia; Iolanda Vincelli; Ida Carmosino; Patrizia Guglielmo; Domenico Pastore; Caterina Alati; Roberto Latagliata
Journal:  Haematologica       Date:  2011-02-17       Impact factor: 9.941

2.  Administration of recombinant human erythropoietin alpha before autologous stem cell transplantation reduces transfusion requirement in multiple myeloma patients.

Authors:  Massimo Martino; Esther Oliva; Giuseppe Console; Caterina Stelitano; Mohamed Fujo; Giuseppe Messina; Giuseppe Irrera; Giulia Pucci; Rosalba Mandaglio; Vincenzo Callea; Francesco Nobile; Pasquale Iacopino; Fortunato Morabito
Journal:  Support Care Cancer       Date:  2004-10-06       Impact factor: 3.603

3.  Early lenalidomide treatment for low and intermediate-1 International Prognostic Scoring System risk myelodysplastic syndromes with del(5q) before transfusion dependence.

Authors:  Esther N Oliva; Michael Lauseker; Maria Antonietta Aloe Spiriti; Antonella Poloni; Agostino Cortelezzi; Giuseppe A Palumbo; Enrico Balleari; Grazia Sanpaolo; Antonio Volpe; Alessandra Ricco; Francesca Ronco; Caterina Alati; Maria Grazia D'Errigo; Irene Santacaterina; Andrea Kündgen; Ulrich Germing; Roberto Latagliata
Journal:  Cancer Med       Date:  2015-09-17       Impact factor: 4.452

4.  Comparisons of commonly used front-line regimens on survival outcomes in patients aged 70 years and older with acute myeloid leukemia.

Authors:  Chetasi Talati; Varun C Dhulipala; Mar Tine Extermann; Najla Al Ali; Jongphil Kim; Rami Komrokji; Kendra Sweet; Andrew Kuykendall; Marina Sehovic; Tea Reljic; Benjamin Djulbegovic; Jeffrey E Lancet
Journal:  Haematologica       Date:  2020-01-31       Impact factor: 9.941

5.  Core set of patient-reported outcomes for myelodysplastic syndromes: an EUMDS Delphi study involving patients and hematologists.

Authors:  Igor Stojkov; Annette Conrads-Frank; Ursula Rochau; Karin A Koinig; Marjan Arvandi; Sibylle Puntscher; Corine van Marrewijk; Pierre Fenaux; Argiris Symeonidis; Fatiha Chermat; Hege Garelius; David Bowen; Moshe Mittelman; Elvira Mora; Theo de Witte; Fabio Efficace; Uwe Siebert; Reinhard Stauder
Journal:  Blood Adv       Date:  2022-01-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.